L
Lykon
Biotech & Life Sciences · Berlin, Germany · Founded 2015
An innovative health care company that provides digital health coaching based on Biomarker analysis MoreLess
Lykon operates in the personalized health and wellness market, offering at-home blood and DNA tests to help individuals optimize their diet and nutrient intake. The company serves health-conscious consumers looking to tailor their dietary and lifestyle choices based on their unique genetic and metabolic profiles. Lykon's business model revolves around selling test kits directly to consumers through their website, as well as offering subscription-based services for ongoing health monitoring and personalized recommendations. Revenue is generated from the sale of these test kits and subscription services. The company leverages advanced biotechnology to provide actionable insights, making it easier for clients to achieve their health and wellness goals.
Keywords: personalized health, at-home tests, blood analysis, DNA analysis, diet optimization, nutrient balance, genetic profiling, health monitoring, biotechnology, wellness.
Company overview
Lykon company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2015
- Headquarters
- Berlin, Germany
- Employees
- 29
- Open positions
- None listed
- Dealroom signal
- 65.5
- Investment activity
- 1 companies · latest Jun 2021
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
Lykon funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jun 2024 | $0 | — | Lifesum | ↗ |
| EARLY VC✓Equity / VC | Aug 2023 | $2.8M | $55M | ZINTINUS | ↗ |
| SERIES A✓Equity / VC | Sep 2022 | $11M | $44M | MA Ventures · ZINTINUS · BTG Bridge To Growth · Ippen Media | ↗ |
| DEBT✓Debt | Aug 2022 | $0 | — | Redstone | — |
| SEED✓Equity / VC | Jun 2021 | $7M | $28M | Ippen Media · MA Ventures | — |
| SEED✓Equity / VC | Jan 2016 | Undisclosed | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
Growth signals
Lykon website traffic
Latest recorded traffic for Lykon is 39K monthly website visits, up 85.7% over the last three months. Lykon's team declined 19.4% over the past year.
Comparisons
Lykon compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Lykon investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
Lykon's talent
Source: Dealroom Talent Intelligence.
Investors
11 investors on Lykon's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Lykon has talent and traffic
team presence
In the news
Latest news about Lykon
Recent press, funding announcements, and product moves mentioning Lykon — open to read from the original sources.
Market sentiment
What the market is saying about Lykon
An AI-synthesized read of the highest-engagement posts about Lykon on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lykon’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.